Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen.

This article reviews recent advances in the biochemistry and molecular biology of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific pulmonary carcinogen believed to be involved in the induction of lung cancer in smokers. Several aspects of NNK bioactivation are addressed, including identification of its metabolites in laboratory animals and humans, cytochrome P450 enzyme involvement in its metabolic activation, DNA and protein adduct formation, biological significance of the major DNA adducts formed, and mutations in oncogenes from tumors induced by NNK. Collectively, the presently available data provide a reasonably clear picture of NNK bioactivation in rodents, although there are still important gaps in our mechanistic understanding of NNK-induced tumorigenesis. The studies in rodents and primates have facilitated development of methods to assess NNK bioactivation in humans, which will be applicable to studies of lung cancer susceptibility and prevention.

[1]  S. Hecht,et al.  Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[2]  S. Murphy,et al.  Glucuronidation of 4-((hydroxymethyl)nitrosamino)-1-(3-pyridyl)-1-butanone, a metabolically activated form of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, by phenobarbital-treated rats. , 1995, Chemical research in toxicology.

[3]  S. Hecht,et al.  Formation of NADP(H) analogs of tobacco-specific nitrosamines in rat liver and pancreatic microsomes. , 1994, Chemical research in toxicology.

[4]  V. Feron,et al.  Immunocytochemical identification of DNA adducts, O6-methylguanine and 7-methylguanine, in respiratory and other tissues of rat, mouse and Syrian hamster exposed to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 1994, Carcinogenesis.

[5]  M. You,et al.  Ki‐ras mutations in 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone—initiated and butylated hydroxytoluene—promoted lung tumors in A/J mice , 1994, Molecular carcinogenesis.

[6]  S Nesnow,et al.  N-nitrosodiethylamine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced morphological transformation of C3H/10T1/2CL8 cells expressing human cytochrome P450 2A6. , 1994, Mutation research.

[7]  S. Murphy,et al.  Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  S. Hecht,et al.  Evidence supporting the role of DNA pyridyloxobutylation in rat nasal carcinogenesis by tobacco-specific nitrosamines. , 1994, Cancer research.

[9]  H. Schuller,et al.  DNA single-strand breaks and toxicity induced by 4-(methyl-nitrosamino)-1-(3- pyridyl)-1-butanone or N-nitrosodimethylamine in hamster and rat liver. , 1994, Carcinogenesis.

[10]  S. Hecht,et al.  Tobacco-specific nitrosamine-hemoglobin adducts. , 1994, Methods in enzymology.

[11]  S. Hecht,et al.  A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. , 1993, The New England journal of medicine.

[12]  Z. Ronai,et al.  G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents. , 1993, Carcinogenesis.

[13]  S. Amin,et al.  Identification of 4-(methylnitrosamino)-1-[3-(6-hydroxypyridyl)]-1-butanone as a urinary metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rodents. , 1993, Chemical research in toxicology.

[14]  M. Desrochers,et al.  Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human kidney epithelial cells transfected with rat CYP2B1 cDNA. , 1993, Carcinogenesis.

[15]  M. You,et al.  Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors. , 1993, Carcinogenesis.

[16]  P. Thomas,et al.  Mechanisms of inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation in mouse by dietary phenethyl isothiocyanate. , 1993, Cancer research.

[17]  F. Gonzalez,et al.  Retroviral mediated expression of human cytochrome P450 2A6 in C3H/10T1/2 cells confers transformability by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). , 1993, Carcinogenesis.

[18]  S. Hecht,et al.  Pyridyloxobutyl DNA adducts inhibit the repair of O6-methylguanine. , 1993, Cancer research.

[19]  R. Padmanabhan,et al.  K-ras and p53 point mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced hamster lung tumors. , 1993, Carcinogenesis.

[20]  S. Hecht,et al.  Tobacco-specific nitrosamine adducts: studies in laboratory animals and humans. , 1993, Environmental health perspectives.

[21]  S. Murphy,et al.  Two types of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone hemoglobin adducts, from metabolites which migrate into or are formed in red blood cells. , 1993, Cancer research.

[22]  S. Hecht,et al.  Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. , 1993, Cancer research.

[23]  F. Gonzalez,et al.  Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6. , 1993, Pharmacogenetics.

[24]  L. Anderson,et al.  Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the patas monkey: pharmacokinetics and characterization of glucuronide metabolites. , 1993, Carcinogenesis.

[25]  R Mustonen,et al.  Smoking-related DNA adducts: 32P-postlabeling analysis of 7-methylguanine in human bronchial and lymphocyte DNA. , 1993, Carcinogenesis.

[26]  Marshall W. Anderson,et al.  Comparison of pulmonary O6‐methylguanine dna adduct levels and Ki‐ras activation in lung tumors from resistant and susceptible mouse strains , 1993, Molecular carcinogenesis.

[27]  M. J. Coon,et al.  Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific carcinogen, by rabbit nasal microsomes and cytochrome P450s NMa and NMb. , 1992, Carcinogenesis.

[28]  E. Richter,et al.  Biliary excretion of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the rat. , 1992, Carcinogenesis.

[29]  K. Hemminki,et al.  7-Methylguanine levels in DNA of smokers' and non-smokers' total white blood cells, granulocytes and lymphocytes. , 1992, Carcinogenesis.

[30]  S. Gerson,et al.  Lack of correlation between DNA methylation and hepatocarcinogenesis in rats and hamsters treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 1992, Carcinogenesis.

[31]  P. Thomas,et al.  Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by inducible and constitutive cytochrome P450 enzymes in rats. , 1992, Archives of biochemistry and biophysics.

[32]  H. Yamazaki,et al.  Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. , 1992, Carcinogenesis.

[33]  Jun-yan Hong,et al.  Kinetics and enzyme involvement in the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in microsomes of rat lung and nasal mucosa. , 1992, Carcinogenesis.

[34]  F. Chung,et al.  Increased 8-oxodeoxyguanosine levels in lung DNA of A/J mice and F344 rats treated with the tobacco-specific nitrosamine 4-(methylnitrosamine)-1-(3-pyridyl)-1-butanone. , 1992, Carcinogenesis.

[35]  S. Belinsky,et al.  Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse. , 1992, Cancer research.

[36]  Z. Ronai,et al.  Analysis of mutagenic activity and ability to induce replication of polyoma DNA sequences by different model metabolites of the carcinogenic tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 1992, Mutation research.

[37]  E. Frei,et al.  1-C-glucuronidation of N-nitrosodiethylamine and N-nitrosomethyl-n-pentylamine in vivo and in primary hepatocytes from rats pretreated with inducers. , 1992, Carcinogenesis.

[38]  S. Rodenhuis,et al.  Clinical significance of ras oncogene activation in human lung cancer. , 1992, Cancer research.

[39]  F. Guengerich,et al.  Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. , 1992, Cancer research.

[40]  S. Hecht,et al.  Evidence that a hemoglobin adduct of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a 4-(3-pyridyl)-4-oxobutyl carboxylic acid ester. , 1992, Chemical research in toxicology.

[41]  C. S. Yang,et al.  Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytochrome P450IIB1 in a reconstituted system. , 1991, Carcinogenesis.

[42]  A. Castonguay,et al.  Comparison of DNA alkali-labile sites induced by 4-(methylnitrosamino)-1(3-pyridyl)-1-butanone and 4-oxo-4-(3-pyridyl)butanal in rat hepatocytes. , 1991, Carcinogenesis.

[43]  S. Hecht,et al.  In vivo and in vitro persistence of pyridyloxobutyl DNA adducts from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 1991, Carcinogenesis.

[44]  S. Hecht,et al.  O6-methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung. , 1991, Cancer research.

[45]  F. Gonzalez,et al.  A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. , 1991, Carcinogenesis.

[46]  J. Resau,et al.  Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers. , 1991, Chemical research in toxicology.

[47]  Marshall W. Anderson,et al.  Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse. , 1991, Carcinogenesis.

[48]  S. Belinsky,et al.  Role of Clara cells and type II cells in the development of pulmonary tumors in rats and mice following exposure to a tobacco-specific nitrosamine. , 1991, Experimental lung research.

[49]  P. Thomas,et al.  Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes and its inhibition by isothiocyanates. , 1990, Cancer research.

[50]  S. Amin,et al.  Characterization of a glucuronide metabolite of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats. , 1990, Carcinogenesis.

[51]  S. Hecht,et al.  Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff dippers, smokers, and nonsmokers. , 1990, Cancer research.

[52]  S. Hecht,et al.  Evaluation of cysteine adduct formation in rat hemoglobin by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and related compounds. , 1990, Cancer research.

[53]  S. Hecht,et al.  Dose-response study of DNA and hemoglobin adduct formation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. , 1990, Cancer research.

[54]  S. Hecht,et al.  Investigations of metabolic precursors to hemoglobin and DNA adducts of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 1990, Carcinogenesis.

[55]  S. Belinsky,et al.  Dose-response relationship between O6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 1990, Cancer research.

[56]  S. Hecht,et al.  Effects of deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in A/J mice. , 1990, Carcinogenesis.

[57]  M. Alaoui-Jamali,et al.  Cytotoxicity, sister-chromatid exchanges and DNA single-strand breaks induced by 4-oxo-4-(3-pyridyl)butanal, a metabolite of a tobacco-specific N-nitrosamine. , 1990, Mutation research.

[58]  C. S. Yang,et al.  Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation. , 1990, Drug metabolism reviews.

[59]  S. Belinsky,et al.  Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines. , 1989, Cancer research.

[60]  D Hoffmann,et al.  The relevance of tobacco-specific nitrosamines to human cancer. , 1989, Cancer surveys.

[61]  S. Amin,et al.  Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. , 1988, Cancer research.

[62]  M. Dolan,et al.  Cell specific differences in O6-methylguanine-DNA methyltransferase activity and removal of O6-methylguanine in rat pulmonary cells. , 1988, Carcinogenesis.

[63]  S. Belinsky,et al.  Factors regulating activation and DNA alkylation by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone and nitrosodimethylamine in rat lung and isolated lung cells, and the relationship to carcinogenicity. , 1988, Cancer research.

[64]  S. Hecht,et al.  Detection of O6-methyldeoxyguanosine in human placental DNA. , 1988, Cancer research.

[65]  S. Hecht,et al.  Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. , 1988, Carcinogenesis.

[66]  S. Hecht,et al.  Evidence for 4-(3-pyridyl)-4-oxobutylation of DNA in F344 rats treated with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine. , 1988, Carcinogenesis.

[67]  S. Belinsky,et al.  Molecular dosimetry of DNA adduct formation and cell toxicity in rat nasal mucosa following exposure to the tobacco specific nitrosamine 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone and their relationship to induction of neoplasia. , 1987, Cancer research.

[68]  S. Hecht,et al.  Formation of hemoglobin adducts upon treatment of F344 rats with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine. , 1987, Cancer research.

[69]  S. Hecht,et al.  Effects of alpha-deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. , 1987, Carcinogenesis.

[70]  S. Belinsky,et al.  Accumulation and persistence of DNA adducts in respiratory tissue of rats following multiple administrations of the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. , 1986, Cancer research.

[71]  S. Hecht,et al.  Comparative tumorigenicity and DNA methylation in F344 rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosodimethylamine. , 1986, Cancer research.

[72]  E. LaVoie,et al.  On the pharmacokinetics of tobacco-specific N-nitrosamines in Fischer rats. , 1985, Carcinogenesis.

[73]  S. Hecht,et al.  Metabolism of tobacco-specific N-nitrosamines by cultured human tissues. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[74]  S. Hecht,et al.  Comparative carcinogenicity in A/J mice and metabolism by cultured mouse peripheral lung of N'-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, and their analogues. , 1983, Cancer research.

[75]  S. Hecht,et al.  Tissue distribution of the tobacco-specific carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and its metabolites in F344 rats. , 1983, Cancer research.

[76]  S. Hecht,et al.  Effects of α-deuterium substitution on the mutagenicity of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK)1 , 1983 .

[77]  S. Hecht,et al.  Metabolism in the F344 rat of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen. , 1980, Cancer research.

[78]  S. Hecht,et al.  Comparative carcinogenicity in F344 rats of the tobacco-specific nitrosamines, N'-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. , 1980, Cancer research.